These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 7513092)
1. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia. Hohlfeld T; Scharnowski F; Braun M; Schrör K Thromb Haemost; 1994 Jan; 71(1):112-8. PubMed ID: 7513092 [TBL] [Abstract][Full Text] [Related]
2. Korean red ginseng attenuates hypercholesterolemia-enhanced platelet aggregation through suppression of diacylglycerol liberation in high-cholesterol-diet-fed rabbits. Hwang SY; Son DJ; Kim IW; Kim DM; Sohn SH; Lee JJ; Kim SK Phytother Res; 2008 Jun; 22(6):778-83. PubMed ID: 18446850 [TBL] [Abstract][Full Text] [Related]
3. Effects of ticlopidine administered to healthy volunteers on platelet function in whole blood. Heptinstall S; May JA; Glenn JR; Sanderson HM; Dickinson JP; Wilcox RG Thromb Haemost; 1995 Nov; 74(5):1310-5. PubMed ID: 8607115 [TBL] [Abstract][Full Text] [Related]
4. Changes of rabbit platelet function on simultaneous administration of ticlopidine hydrochloride and OKY-046. Kosugi T; Nakamura M; Saitoh S; Kinjoh K Int J Tissue React; 1991; 13(3):123-9. PubMed ID: 1960013 [TBL] [Abstract][Full Text] [Related]
5. Relationship between serum cholesterol and thromboxane B2 levels and atherosclerotic lesions in rabbits fed a high cholesterol diet. Restori G; Boiardi L; Manarini S; Cerletti C; Gelmini G; Barbagallo M; Novo S; Passeri M; Strano A Int Angiol; 1990; 9(4):256-8. PubMed ID: 2099958 [TBL] [Abstract][Full Text] [Related]
7. Oral naftidrofuryl prevents platelet hyperreactivity ex vivo and inhibits functional desensitization to prostacyclin in hypercholesterolemic rabbits. Weber AA; Hohlfeld T; Strobach H; Schrör K J Cardiovasc Pharmacol; 1993 Feb; 21(2):332-8. PubMed ID: 7679170 [TBL] [Abstract][Full Text] [Related]
8. Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit. Honey AC; Lad N; Tuffin DP Thromb Haemost; 1986 Aug; 56(1):80-5. PubMed ID: 3775692 [TBL] [Abstract][Full Text] [Related]
9. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species. Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866 [TBL] [Abstract][Full Text] [Related]
10. ADP plays a key role in thrombogenesis in rats. Maffrand JP; Bernat A; Delebassée D; Defreyn G; Cazenave JP; Gordon JL Thromb Haemost; 1988 Apr; 59(2):225-30. PubMed ID: 3133809 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients. Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of ticlopidine: relation between dose and time of administration to platelet inhibition. Kuzniar J; Splawinska B; Malinga K; Mazurek AP; Splawinski J Int J Clin Pharmacol Ther; 1996 Aug; 34(8):357-61. PubMed ID: 8864800 [TBL] [Abstract][Full Text] [Related]
13. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity. Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663 [TBL] [Abstract][Full Text] [Related]
14. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine. Wang J; Albertson CM; Zheng H; Fink LM; Herbert JM; Hauer-Jensen M Thromb Haemost; 2002 Jan; 87(1):122-8. PubMed ID: 11848440 [TBL] [Abstract][Full Text] [Related]
15. Changes in some aspects of platelet function with improvement of glycaemic control over 6 months. Collier A; Tymkewycz PM; Matthews DM; Jones RL; Clarke BF Diabetes Res; 1987 Jun; 5(2):79-82. PubMed ID: 2443296 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity. Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699 [TBL] [Abstract][Full Text] [Related]
17. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease. Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480 [TBL] [Abstract][Full Text] [Related]
18. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Jagroop IA; Matsagas MI; Geroulakos G; Mikhailidis DP Platelets; 2004 Mar; 15(2):117-25. PubMed ID: 15154604 [TBL] [Abstract][Full Text] [Related]
19. ADP-induced second wave aggregation in platelet rich plasma from hypercholesterolemic rabbits. Weber A; Hohlfeld T; Schrör K Thromb Res; 1991 Dec; 64(6):703-12. PubMed ID: 1798959 [TBL] [Abstract][Full Text] [Related]
20. Comparison of collagen versus adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease. Li J; Jian Z; Huang L; Guo H; Huang J; Qian D; Fu W; Li A; Song Y Biomed Pharmacother; 2009 Sep; 63(8):608-12. PubMed ID: 19019624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]